|
Market Closed -
Saudi Arabian S.E.
08:20:00 2026-08-16 EDT
|
5-day change | 1st Jan Change | ||
| 59.55 SAR | -1.57% |
|
-2.85% | -6.28% |
| 08-10 | Avalon Pharma Declares H1 Dividend | MT |
| 08-09 | Middle East Pharmaceutical Industries Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Company Valuation: Middle East Pharmaceutical Industries Company
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 |
|---|---|---|
| Market Cap 1 | 2,436 | 2,224 |
| Change | - | -8.7% |
| Enterprise Value (EV) 1 | 2,479 | 2,253 |
| Change | - | -9.09% |
| P/E | 30.5x | 22.9x |
| PBR | 6.62x | 5.34x |
| PEG | 1.4x | 1.1x |
| Capitalization / Revenue | 6.18x | 4.83x |
| EV / Revenue | 6.29x | 4.89x |
| EV / EBITDA | 25x | 18.9x |
| EV / EBIT | 27.8x | 21.1x |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Dividend per Share 2 | 1.143 | 1.383 |
| Rate of return | 1.64% | 2.18% |
| EPS 2 | 2.281 | 2.772 |
| Distribution rate | 50.1% | 49.9% |
| Net sales 1 | 394 | 460.5 |
| EBITDA 1 | 99.08 | 119.1 |
| EBIT 1 | 89.29 | 106.9 |
| Net income 1 | 79.85 | 97.01 |
| Net Debt 1 | 42.83 | 29.47 |
| Reference price 2 | 69.60 | 63.54 |
| Nbr of stocks (in thousands) | 35,000 | 35,000 |
| Announcement Date | 3/27/25 | 3/8/26 |
1SAR in Million2SAR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 564M | |
| 35.61x | 6.69x | 23.16x | 0.89% | 48.43B | |
| 18.56x | 2.2x | 10x | 1.37% | 39.72B | |
| 28.23x | 3.44x | 17.81x | 0.9% | 12.25B | |
| 27.22x | 3.89x | 16.12x | 0.59% | 11.84B | |
| 18.63x | 3.31x | 11.51x | 3.87% | 9.06B | |
| 9.11x | 2.11x | 5.48x | 4.42% | 7.57B | |
| 15.83x | 2.06x | 6.7x | 3.22% | 7.18B | |
| 35.19x | 4.02x | 17.09x | 0.23% | 6.84B | |
| Average | 23.55x | 3.46x | 13.48x | 1.94% | 15.94B | |
| Weighted average by Cap. | 26.05x | 4.11x | 15.67x | 1.46% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 4016 Stock
- Valuation Middle East Pharmaceutical Industries Company
Select your edition
All financial news and data tailored to specific country editions
